| Non-survivors n = 67 | Survivors n = 327 | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|---|
 |  |  | OR (95% CI) | p-value | aOR (95% CI) | p-value |
Birth weight categories | Â | Â | Â | Â | N/A | Â |
 ≥ 2500 g | 56 (83.6) | 291 (89.0) | 1 | _ |  |  |
 < 2500 g | 11 (16.4) | 36 (11.0) | 0.63 (0.30–1.31) | 0.213 |  |  |
Gestational age categories | Â | Â | Â | Â | Â | Â |
 ≥ 38 weeks | 46 (69.7) | 217 (66.4) | 1 | _ | 1 | _ |
 < 38 weeks | 20 (30.3) | 63 (19.3) | 1.82 (1.00–3.31) | 0.045 | 1.47 (0.70–3.11) | 0.307 |
Sex | Â | Â | Â | Â | N/A | Â |
 Female | 27 (40.3) | 122 (37.5) | 1 | _ |  |  |
 Male | 40 (59.7) | 203 (62.5) | 0.89 (0.52–1.52) | 0.672 |  |  |
Apgar score at 5Â min | Â | Â | Â | Â | N/A | Â |
 ≥ 4 | 52/66 (78.8) | 275/321 (85.7) | 1 | _ |  |  |
 0–3 | 14/66 (21.2) | 46/321 (14.3) | 1.61 (0.82–3.15) | 0.16 |  |  |
Time to First Breath | ||||||
 < 20 min | 35/48 (72.9) | 220/251 (87.6) | 1 | _ | 1 | _ |
 ≥ 20 min | 13/48 (27.1) | 31/251 (12.4) | 2.64 (1.25–5.58) | 0.008 | 1.86 (0.74–4.63) | 0.184 |
Sarnat staging | ||||||
 Stage 2 (moderate encephalopathy) | 48/67 (71.6) | 306/327 (93.6) | 1 | _ | 1 | _ |
 Stage 3 (severe encephalopathy) | 19/67 (28.4) | 21/327 (6.42) | 5.77 (2.81–11.8) | 0.001 | 2.04 (0.74–5.67 | 0.17 |
Thompson score | ||||||
 ≤ 10 | 22/65 (33.8) | 163/314 (51.9) | 1 | _ | 1 |  |
 > 10 | 43/65 (66.2) | 151/314 (48.1) | 2.11 (1.20–3.71) | 0.008 | 1.52 (0.75–3.08) | 0.248 |
Blood gas, pH | ||||||
 ≥ 7.00 | 36/67 (53.7) | 214/326 (65.6) | 1 | _ | 1 |  |
 < 7.00 | 31/67 (46.3) | 112/326 (34.4) | 1.65 (0.96–2.81) | 0.065 | 1.01 (0.51–2.00) | 0.981 |
Blood gas, base deficit (mmols/L) | Â | Â | Â | Â | N/A | Â |
 ≤ 16 | 17/66 (25.8) | 85/320 (26.6) | 1 | _ |  |  |
 > 16 | 49/66 (74.2) | 235/320 (73.4) | 1.04 (0.57–1.91) | 0.893 |  |  |